CBX Therapeutics
Agent34 out of 100, Below median. Agent Readiness. Open the scores section.Agent Readiness: 34/100. Below median. Measured by StartupHub.ai. Median 41.Trust85 out of 100, Top 25%. Data Trust. Open the scores section.Data Trust: 85/100. Top 25%. Measured by StartupHub.ai. Median 61.CBX Therapeutics is a biotechnology company focused on developing novel therapies for cancer.
About
CBX Therapeutics is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutics for the treatment of cancer. The company's lead program targets a novel pathway implicated in tumor growth and metastasis, with the aim of providing new options for patients with unmet medical needs.
Listed competitors
Also in this space
AI-driven digital twin of embryo development for cell-based therapies.
Shares Life Sciences, Therapeutics
Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.
Shares Life Sciences, Therapeutics
AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.
Shares Life Sciences, Therapeutics
AI-powered patient-centric drug simulations to accelerate and de-risk drug development.
Shares Life Sciences, Clinical Trials
AI-powered blood test for early cancer detection and subtyping.
Shares Life Sciences, Biotech
Omnix Medical is developing a novel platform for advanced wound care management.
Shares Life Sciences, Biotech
Key facts
- Website
- cbxtherapeutics.com
- Headquarters
- Cambridge, United States
- Founded
- 2023
- Business model
- B2B
Test your Agent Readiness
How well ChatGPT, Claude and the other agents can read and use a site. About a minute.
Frequently asked
Is CBX Therapeutics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for CBX Therapeutics is 85 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
SEC filings, insider activity, nonprofit links and pay benchmarks for CBX Therapeutics:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
